
We've closed a $48.5M #SeriesA financing round. This funding supports our #PremarketApproval submission for the #ReviventTC, expanding access to allow additional procedures. We've also appointed Raphael Wisniewski & Bihua Chen to our Board of Directors: prn.to/4005YTC

English

















